Your session is about to expire
← Back to Search
Topical Analgesic
Vehicle Patch for Musculoskeletal Disease
N/A
Waitlist Available
Led By Roland Staud, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 hr
Awards & highlights
No Placebo-Only Group
Summary
This trial involves applying a cream with capsaicin, a substance from chili peppers, to the skin of fibromyalgia patients. The goal is to see if their increased pain sensitivity is due to changes in their brain and spinal cord. Researchers will compare their pain response over time to understand if central mechanisms are responsible for their pain. Capsaicin has been used for various pain conditions.
Eligible Conditions
- Musculoskeletal Disease
- Fibromyalgia
- Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 hr
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 hr
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Progression of Temporal Summation of Second Pain
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Vehicle PatchExperimental Treatment1 Intervention
Control patch will be the same topical solution but will not contain capsaicin. The patch will applied to the hand for 30 - 60 min. Patients will be instructed to not touch or wash their hands during the course of the study to minimize spreading of the patch to other areas of the body. Subsequently, the patch will be immediately removed.
Group II: Capsaicin Patch 8% or 0.1% Capsaicin CreamExperimental Treatment1 Intervention
8% capsaicin topical patch or 0.1% capsaicin cream. The patch will applied to the hand for 30 - 60 min. The cream will be applied similarly on a 3 cm2 area of the arm. Patients will be instructed to not touch or wash their hands during the course of the study to minimize spreading of the patch to other areas of the body. Subsequently, the patch will be immediately removed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Capsaicin Patch 8% or 0.1% Capsaicin Cream
2018
N/A
~60
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,398 Previous Clinical Trials
766,976 Total Patients Enrolled
Roland Staud, MDPrincipal InvestigatorUniversity of Florida
4 Previous Clinical Trials
388 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger